Cardinal Spine

Louisville, United States Founded: 2008 • Age: 18 yrs Acquired By K2M
Interbody fusion devices are developed to stabilize spinal implants.

About Cardinal Spine

Cardinal Spine is a Healthcare company based in Louisville (United States) founded in 2008, and was acquired by K2M in October 2017. Interbody fusion devices are developed to stabilize spinal implants. Cardinal Spine has raised $747.5 thousand across 1 funding round from investors including K2M. The company was acqui-hired. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Nevro, Vertos Medical and Paradigm Spine; 3 of its 3 listed competitors have raised funding.

Company details

Cardinal Spine is developing inter body fusion devices designed to stabilise spinal implants. They have developed, C-VBR - a vertebral body replacement device indicated for use in the cervical spine; STGC - a rectangular vertebral body replacement device having a trapezoidal cross section; STCC - an interbody spacer for the cervical spine. Their devices have received FDA 510(k) clearance.

  • Headquarters Louisville, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website cardinalspine.net
  • Acquired by K2M (Oct 2017)
Operational Areas
Key Metrics
  • Total Equity Funding
    $747.5K (USD)

    in 1 rounds

  • Latest Funding Round
    $747.5K (USD), Seed

    Dec 2016

  • Investors
  • Acquired by
    K2M

    (Oct 2017)

Funding Insights of Cardinal Spine

Cardinal Spine has successfully raised a total of $747.5K through 1 strategic funding round. The most recent funding activity was a Seed round of $747.5 thousand completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $747,500
  • Total Rounds 1
  • Last Round Seed β€” $747,500
  • First Round $747,500

    (Dec 2016)

All 1 funding rounds of Cardinal Spine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2016$747,500Seed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Cardinal Spine

Cardinal Spine has secured backing from 1 investor. Prominent investors backing the company include K2M.

All
InvestorDescriptionFounded YearDomainLocation
Devices for complex spinal disorders are developed using advanced technologies.
2004k2m.comLeesburg, United States
Premium access

Investor details for Cardinal Spine

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Cardinal Spine

3 dated milestones of Cardinal Spine across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cardinal Spine is founded.
  2. Funding First funding round of $748K.
  3. Exit Acquired by K2M.

Competitors of Cardinal Spine

Cardinal Spine has 3 listed competitors in our database, 3 of them funded. They include Nevro, Vertos Medical and Paradigm Spine.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nevro.com2006Menlo Park, United States$154.1M1,215
Provider of high-frequency spinal cord stimulation implants
vertosmed.com2005Aliso Viejo, United States$177.75M140
Minimally invasive treatments for lumbar spinal stenosis are developed.
paradigmspine.com2005New York, United States$142.15M43
Stabilization devices for healthcare are manufactured by the company.
Premium access

Detailed competitors of Cardinal Spine

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Orthopedics

3 companies that operate in the same segment as Cardinal Spine (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cardinal Spine

Cardinal Spine was founded in 2008 and raised its 1st funding round 8 years after it was founded.

Cardinal Spine is headquartered in Louisville, United States. It is registered at Louisville, Kentucky, United States.

Cardinal Spine is a funded company, having raised a total of $747.5K across 1 funding round to date. The company's 1st funding round was a Seed of $747.5K, raised on Dec 2016.

Cardinal Spine is developing inter body fusion devices designed to stabilise spinal implants. They have developed, C-VBR - a vertebral body replacement device indicated for use in the cervical spine; STGC - a rectangular vertebral body replacement device having a trapezoidal cross section; STCC - an interbody spacer for the cervical spine. Their devices have received FDA 510(k) clearance.

Cardinal Spine's top competitors include Nevro, Paradigm Spine and Vertos Medical.

Cardinal Spine has 1 investor. Key investors include K2M.

Yes. Cardinal Spine was acquired by K2M in October 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available